Employees Retirement System Of Texas Vertex Pharmaceuticals Inc Transaction History

Employees Retirement System Of Texas

$11.6 Billion
Q3 2024

A detailed history of Employees Retirement System Of Texas transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Employees Retirement System Of Texas holds 118,000 shares of VRTX stock, worth $53.2 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

118,000

Previous 118,000 -0.0%

Holding current value

$53.2 Million

Previous $55.3 Million 0.78%

% of portfolio

0.47%

Previous 0.52%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$338.18 - $362.46 $2.37 Million - $2.54 Million	7,000 Added 6.31%	118,000 $41 Million
Q2 2023 Aug 10, 2023	BUY	$314.42 - $351.91 $34.9 Million - $39.1 Million	111,000 New	111,000 $39.1 Million
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $4.33 Million - $4.83 Million	15,800 Added 24.23%	81,000 $23.5 Million
Q2 2022 Aug 08, 2022	BUY	$234.96 - $292.55 $5.4 Million - $6.73 Million	23,000 Added 54.5%	65,200 $18.4 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $417,196 - $466,877	-2,300 Reduced 5.17%	42,200 $7.66 Million
Q2 2021 Aug 10, 2021	SELL	$187.49 - $221.1 $2.01 Million - $2.37 Million	-10,700 Reduced 19.38%	44,500 $8.97 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $11.4 Million - $13.3 Million	55,200 New	55,200 $11.9 Million
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $19.9 Million - $26.6 Million	-96,200 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$225.48 - $295.8 $1.42 Million - $1.86 Million	-6,300 Reduced 6.15%	96,200 $27.9 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $3.4 Million - $4.21 Million	17,000 Added 19.88%	102,500 $24.4 Million
Q4 2019 Feb 10, 2020	SELL	$166.71 - $223.91 $2.5 Million - $3.36 Million	-15,000 Reduced 14.93%	85,500 $18.7 Million
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $2.24 Million - $2.53 Million	13,500 Added 15.52%	100,500 $17 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $164,610 - $190,370	-1,000 Reduced 1.14%	87,000 $16 Million
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $7.7 Million - $9.15 Million	47,000 Added 114.63%	88,000 $16.2 Million
Q4 2018 Feb 12, 2019	SELL	$151.91 - $192.21 $3.8 Million - $4.81 Million	-25,000 Reduced 37.88%	41,000 $6.79 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $335,460 - $385,480	-2,000 Reduced 2.94%	66,000 $12.7 Million
Q2 2018 Aug 10, 2018	SELL	$145.72 - $169.96 $3.21 Million - $3.74 Million	-22,000 Reduced 24.44%	68,000 $11.6 Million
Q1 2018 May 11, 2018	SELL	$151.6 - $177.13 $4.85 Million - $5.67 Million	-32,000 Reduced 26.23%	90,000 $14.7 Million
Q4 2017 Feb 09, 2018	SELL	$137.28 - $155.55 $137,280 - $155,550	-1,000 Reduced 0.81%	122,000 $18.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	123,000	123,000 $15.9 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.

Account

Employees Retirement System Of Texas Vertex Pharmaceuticals Inc Transaction History